Home
DONATE

Yujuan Zhang, MD

The Role of IL-1 in sJIA Monocyte Phenotypes | Stanford University | Award Period: July 2012-June 2014

The Researcher’s Summary:

Systemic idiopathic juvenile arthritis (SJIA) is a chronic childhood disease that causes arthritis, fever, rash and other kinds of inflammation (e.g., around the heart and lungs). It is unknown what causes this disease, or what drives one of its main complications, called macrophage activation syndrome.

Notably, some patients respond to medication that inhibits IL-1, an inflammatory mediator made by the body. In conjunction with a trial of the IL-1 inhibitor rilanocept, we propose to investigate how IL-1 affects a particular immune cell type: the monocyte, which appears to be a key cell in SJIA pathology. We also hope to identify changes in monocytes during disease that predict response to rilanocept.

 

Meet Other Families

Meet Other Families

JA CONFERENCE

CAMPS

MORE...

What's Happening Near You?

Speak to someone in your local area about the latest JA programs and events.

Find Local Contact

KGAT News Updates

Get the quarterly JA e-newsletter and receive the latest information about JA news, events and more.

 

Yujuan Zhang, MD

The Role of IL-1 in sJIA Monocyte Phenotypes | Stanford University | Award Period: July 2012-June 2014


The Researcher’s Summary:

Systemic idiopathic juvenile arthritis (SJIA) is a chronic childhood disease that causes arthritis, fever, rash and other kinds of inflammation (e.g., around the heart and lungs). It is unknown what causes this disease, or what drives one of its main complications, called macrophage activation syndrome.

Notably, some patients respond to medication that inhibits IL-1, an inflammatory mediator made by the body. In conjunction with a trial of the IL-1 inhibitor rilanocept, we propose to investigate how IL-1 affects a particular immune cell type: the monocyte, which appears to be a key cell in SJIA pathology. We also hope to identify changes in monocytes during disease that predict response to rilanocept.